Viewing nowCombinationCredible Tablets 10/5 mg (Ezetimibe, Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 201601207 · Approved 2016.02.29 · Insurance code 645305440
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication is used to lower total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels, and to increase HDL cholesterol levels in patients with primary hypercholesterolemia, including familial and non-familial hypercholesterolemia, and mixed dyslipidemia. It is important to restrict the intake of saturated fats and cholesterol as it is administered alongside diet therapy and is recommended as an adjunctive treatment when diet therapy alone is insufficient. Furthermore, it is used to reduce the risk of atherosclerotic vascular disease caused by hypercholesterolemia, and prior to treatment, it is essential to confirm secondary causes such as diabetes and hypothyroidism and treat them if necessary. During the treatment process, total cholesterol, LDL, HDL, and triglycerides should be regularly monitored to evaluate the treatment effect. In cases of acute coronary syndrome, lipid levels should be measured upon admission or within 24 hours, and LDL-lowering treatment may be initiated before discharge. This medication helps reduce health risks associated with dyslipidemia.
This medicine is taken once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients who are taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
There is a risk of serious muscle problems with this medication, so if symptoms of muscle pain or weakness occur, notify a doctor immediately. In cases of severe infection, hypotension, major surgery or trauma, metabolic abnormalities, etc., the use of this medication may need to be temporarily halted or stopped. Patients with allergies to the components of this medication, severe liver disease, muscle disorders, severely impaired kidney function, or who are pregnant or nursing should not use this medication. Patients at high risk for myopathy or rhabdomyolysis should use this medication with caution and should have muscle enzyme levels checked before and during treatment. Patients with liver dysfunction or alcohol dependency should also be cautious when using this medication. This medication may elevate liver enzyme levels, requiring regular liver function tests before and during treatment. If symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, fever, etc., occur during the use of this medication, inform a doctor immediately, and if necessary, blood tests should be performed to check for muscle damage. This medication may interact with other drugs, so inform a doctor or pharmacist of any other medications being taken. Particularly caution is needed when used with anticoagulants, fibrates, certain antibiotics, antifungal agents, etc. Women of childbearing age must use appropriate contraception while taking this medication, and if pregnancy is confirmed, discontinue immediately. Safety in children and adolescents has not been sufficiently established, thus it is not recommended. Elderly patients are at higher risk for muscle issues and should use this medication cautiously, with dosage adjustments as necessary. There is no specific antidote for overdose, and treatment should be symptomatic with supportive care, along with liver function and muscle enzyme tests required. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.
Acute kidney failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, increased ALT, increased AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, strange sensation, drug intolerance, colorectal polyp, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, vascular swelling, hypersensitivity reactions, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, asthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorders, confusion, severe muscle weakness, ophthalmoplegia, increased CK, chest pain, cough, myalgia, increased CK, constipation, asthenia, arthralgia, fatigue, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased serum creatinine, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, cough, chest pain, fatigue, bloating, nausea, increased AST, increased ALT, low back pain, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbance, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival congestion, renal failure, increased serum creatinine, elevated blood pressure, increased serum urea
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid contact with air or moisture, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and ensure safety during use.
White to nearly white round film-coated tablets
30 tablets (10 tablets/PTP packaging x 3), 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.